Szerző: " Fonseca Francisco"

Ridker Paul M.; MacFadyen Jean G.; Everett Brendan M.; Libby Peter; Thuren Tom; Glyn Robert J.; Kollaborációs szervezet: CANTOS Trial Group; Kastelein John; Koenig Wolfgang; Genest Jacques; Lorenzatti Alberto; Varigos John; Siostrzonek Peter; Sinnaeve Peter; Fonseca Francisco; Forster Tamás (kollab. közrem.): Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
LANCET, 391 (10118). pp. 319-328. ISSN 0140-6736 (2018)

Ridker Paul M.; Everett Brendan M.; Thuren Tom; MacFadyen Jean G.; Chang W. H.; Ballantyne C.; Fonseca Francisco; Nicolau J.; Koenig W.; Forster Tamás; et. al.; CANTOS Trial Group; Kiss Róbert Gábor; László Zoltán; Merkely Béla Péter; Sárszegi Zsolt; Benedek Imre-Sándor; et al. (kollab. közrem.): Antiinflammatory therapy with canakinumab for atherosclerotic disease.
NEW ENGLAND JOURNAL OF MEDICINE, 377 (12). pp. 1119-1131. ISSN 0028-4793 (2017)

Ridker Paul M.; MacFadyen Jean G.; Thuren Tom; Everett Brendan M.; Libby Peter; Glynn Robert J.; CANTOS Trial Group; Forster Tamás; Ridker Paul; Lorenzatti Alberto; Krum Henry; Varigos John; Siostrzonek Peter; Sinnaeve Peter; Fonseca Francisco; et al. (kollab. közrem.): Effect of interleukin-1 beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
LANCET, 390 (10105). pp. 1833-1842. ISSN 0140-6736 (2017)